Establishment and characterization of a cell line from smokeless tobacco associated oral squamous cell carcinoma

Oral Oncology

Volumn 39, Issue 8, 2003, Pages 806-820

  Kaur, Jatinder ^a   Ralhan, Ranju ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Aetiology; Cell line; Indian; Oral SCC; Smokeless tobacco

Indexed keywords

ALPHA6 INTEGRIN; CYTOKERATIN 10; CYTOKERATIN 13; CYTOKERATIN 16; CYTOKERATIN 5; EPITHELIAL MEMBRANE ANTIGEN; PROTEIN P21; PROTEIN P53; RETINOIC ACID;

ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MOLECULAR DYNAMICS; MOUTH CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TOBACCO DEPENDENCE;

ANTIOXIDANTS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA MUTATIONAL ANALYSIS; GENES, P53; HUMANS; IMMUNOBLOTTING; KARYOTYPING; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; MOUTH NEOPLASMS; TOBACCO, SMOKELESS; TRETINOIN; TUMOR MARKERS, BIOLOGICAL;

EID: 1642334072     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(03)00084-8     Document Type: Article

References (51)

1. Shields P.G. Epidemiology of tobacco carcinogenesis. Curr Oncol Rep. 2:2000;257-262.
2. Jenson H.B., Heard P., Moyer M.P. Evaluation of the effect of smokeless tobacco purified products and extracts on latent Epstein-Barr virus. Toxicology. 133:1999;35-42.
3. Winn D.M. Epidemiology of cancer and other systemic effects associated with the use of smokeless tobacco. Adv Dent Res. 11:1997;313-321.
4. Agarwal S., Mathur M., Srivastava A., Ralhan R. MDM2/p53 co-expression in oral premalignant and malignant lesions. potential prognostic implications Oral Oncol. 35:1999;209-216.
5. Ralhan R., Sandhya A., Meera M., Bohdan W., Nootan S.K. Induction of MDM2-P2 transcripts correlates with stabilized wild-type p53 in betel- and tobacco-related human oral cancer. Am J Pathol. 157:2000;587-596.
6. Pande P., Soni S., Chakravarti N., Mathur M., Shukla N.K., Ralhan R. Prognostic impact of Ets-1 overexpression in betel and tobacco related oral cancer. Cancer Detect Prev. 25:2001;496-501.
7. Ralhan R., Agarwal S., Mathur M., Wasylyk B., Srivastava A. Correlation between p53 gene mutations and circulating antibodies in betel and tobacco consuming North Indian population. Oral Oncology. 37:2001;243-250.
8. Saranath D., Chang S.E., Bhoite L.T., Panchal R.G., Kerr I.B., Mehta A.R.et al. High frequency mutation in codons 12 and 61 of H-ras oncogene in chewing tobacco-related human oral carcinoma in India. Br J Cancer. 63:1991;573-578.
9. Saranath D., Bhoite L.T., Deo M.G. Molecular lesions in human oral cancer. the Indian scene Eur J Cancer B Oral Oncol. 29B:1993;107-112.
10. Singer K.H., Scearce R.M., Tuck D.T., Whichard L.P., Denning S.M., Haynes B.F. Removal of fibroblasts from human epithelial cell cultures with use of a complement fixing monoclonal antibody reactive with human fibroblasts and monocytes/macrophages. J Invest Dermatol. 92:1989;166-170.
11. Pathak S. Chromosome banding techniques. J Reprod Med. 17:1976;25-28.
12. Stasiak P.C., Purkis P.E., Leigh I.M., Lane E.B. Keratin 19. predicted amino acid sequence and broad tissue distribution suggest it evolved from keratinocyte keratins J Invest Dermatol. 92:1989;707-716.
13. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. procedure and some applications Proc Natl Acad Sci USA. 76:1979;4350-4354.
14. Chakravarti N., Mathur M., Bahadur S., Shukla N.K., Rochette-Egly C., Ralhan R. Expression of RARalpha and RARbeta in human oral potentially malignant and neoplastic lesions. Int J Cancer. 91:2001;27-31.
15. Takahashi I., Amakawa Y. A method for visualizing cytoskeletal structures by the scanning electron microscope. J Electron Microsc (Tokyo). 38:1989;242-245.
16. Sambrook J., Fritsch E.F., Maniatis T. Molecular cloning: a laboratory manual, 2nd ed. 1986;Cold Spring Harbor laboratory Press, Cold Spring Harbor NY.
17. Nigro J.M., Baker S.J., Preisinger A.C., Jessup J.M., Hostetter R., Cleary K.et al. Mutations in the p53 gene occur in diverse human tumour types. Nature. 342:1989;705-708.
18. Patino-Garcia A., Sotillo-Pineiro E., Sierrasesumaga-Ariznabarreta L. p21WAF1 mutation is not a predominant alteration in pediatric bone tumors. Pediatr Res. 43:1998;393-395.
19. Denizot F., Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods. 89:1986;271-277.
20. Bissonnette R.P., Echeverri F., Mahboubi A., Green D.R. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature. 359:1992;552-554.
21. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
22. Rosewicz S., Stier U., Brembeck F., Kaiser A., Papadimitriou C.A., Berdel W.E.et al. Retinoids: effects on growth, differentiation, and nuclear receptor expression in human pancreatic carcinoma cell lines. Gastroenterology. 109:1995;1646-1660.
23. Califano J., van der Riet P., Westra W., Nawroz H., Clayman G., Piantadosi S.et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res. 56:1996;2488-2492.
24. Hedberg J.J., Grafstrom R.C., Vondracek M., Sarang Z., Warngard L., Hoog J.O. Micro-array chip analysis of carbonyl-metabolising enzymes in normal, immortalised and malignant human oral keratinocytes. Cell Mol Life Sci. 58:2001;1719-1726.
25. Alevizos I., Mahadevappa M., Zhang X., Ohyama H., Kohno Y., Posner M.et al. Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis. Oncogene. 20:2001;6196-6204.
26. Stepp M.A., Zhu L., Cranfill R. Changes in beta 4 integrin expression and localization in vivo in response to corneal epithelial injury. Invest Ophthalmol Vis Sci. 37:1996;1593-1601.
27. Kimmel K.A., Carey T.E. Altered expression in squamous cells of an orientation restricted epithelial antigen detected by monoclonal antibody A9. Cancer Res. 46:1986;3614-3623.
28. Doglioni C., Dell'Orto P., Coggi G., Iuzzolino P., Bontempini L., Viale G. Choroid plexus tumors. An immunocytochemical study with particular reference to the coexpression of intermediate filament proteins. Am J Pathol. 127:1987;519-529.
29. Lane E.B., Goodman S.L., Trejdosiewicz L.K. Disruption of the keratin filament network during epithelial cell division. EMBO J. 1:1982;1365-1372.
30. Ahmad A., Hanby A., Dublin E., Poulsom R., Smith P., Barnes D.et al. Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression. Am J Pathol. 152:1998;721-728.
31. Prives C., Hall P.A. The p53 pathway. J Pathol. 187:1999;112-126.
32. Pande P., Soni S., Kaur J., Agarwal S., Mathur M., Shukla N.K.et al. Prognostic factors in betel and tobacco related oral cancer. Oral Oncol. 38:2002;491-499.
33. Liu M., Iavarone A., Freedman L.P. Transcriptional activation of the human p21(WAF1/CIP1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation. J Biol Chem. 271:1996;31723-31728.
34. Gorospe M., Cirielli C., Wang X., Seth P., Capogrossi M.C., Holbrook N.J. p21(Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells. Oncogene. 14:1997;929-935.
35. Hayashi K., Yokozaki H., Naka K., Yasui W., Yajin K., Lotan R.et al. Effect of 9-cis-retinoic acid on oral squamous cell carcinoma cell lines. Cancer Lett. 151:2000;199-208.
36. Hayashi K., Yokozaki H., Naka K., Yasui W., Lotan R., Tahara E. Overexpression of retinoic acid receptor beta induces growth arrest and apoptosis in oral cancer cell lines. Jpn J Cancer Res. 92:2001;42-50.
37. Chakravarti N, Mathur M, Bahadur S, Shukla NK, Ralhan R. Retinoic acid receptor-alpha as a prognostic indicator in oral squamous cell carcinoma. Int J Cancer 2003;103:544-549.
38. Wong C.W., Privalsky M.L. Transcriptional silencing is defined by isoform- and heterodimer-specific interactions between nuclear hormone receptors and corepressors. Mol Cell Biol. 18:1998;5724-5733.
39. Germain P., Iyer J., Zechel C., Gronemeyer H. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy. Nature. 415:2002;187-192.
40. Liu C., Wang X.D., Bronson R.T., Smith D.E., Krinsky N.I., Russell R.M. Effects of physiological versus pharmacological beta-carotene supplementation on cell proliferation and histopathological changes in the lungs of cigarette smoke-exposed ferrets. Carcinogenesis. 21:2000;2245-2253.
41. Xu X.C., Wong W.Y., Goldberg L., Baer S.C., Wolf J.E., Ramsdell W.M.et al. Progressive decreases in nuclear retinoid receptors during skin squamous carcinogenesis. Cancer Res. 61:2001;4306-4310.
42. Klaassen I., Brakenhoff R.H., Smeets S.J., Snow G.B., Braakhuis B.J. Expression of retinoic acid receptor gamma correlates with retinoic acid sensitivity and metabolism in head and neck squamous cell carcinoma cell lines. Int J Cancer. 92:2001;661-665.
43. Andersson G., Bjornberg G., Curvall M. Oral mucosal changes and nicotine disposition in users of Swedish smokeless tobacco products. a comparative study J Oral Pathol Med. 23:1994;161-167.
44. Rosecrans J.A., Karan L.D. Neurobehavioral mechanisms of nicotine action. role in the initiation and maintenance of tobacco dependence J Subst Abuse Treat. 10:1993;161-170.
45. Maneckjee R., Minna J.D. Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines. Proc Natl Acad Sci USA. 87:1990;3294-3298.
46. Chini B., Clementi F., Hukovic N., Sher E. Neuronal-type alpha-bungarotoxin receptors and the alpha 5-nicotinic receptor subunit gene are expressed in neuronal and nonneuronal human cell lines. Proc Natl Acad Sci USA. 89:1992;1572-1576.
47. Quik M., Chan J., Patrick J. alpha-Bungarotoxin blocks the nicotinic receptor mediated increase in cell number in a neuroendocrine cell line. Brain Res. 655:1994;161-167.
48. Schuller H.M., Orloff M. Tobacco-specific carcinogenic nitrosamines. Ligands for nicotinic acetylcholine receptors in human lung cancer cells. Biochem Pharmacol. 55:1998;1377-1384.
49. Arredondo J., Nguyen V.T., Chernyavsky A.I., Jolkovsky D.L., Pinkerton K.E., Grando S.A. A receptor-mediated mechanism of nicotine toxicity in oral keratinocytes. Lab Invest. 81:2001;1653-1668.
50. Chen G.Q., Lin B., Dawson M.I., Zhang X.K. Nicotine modulates the effects of retinoids on growth inhibition and RAR beta expression in lung cancer cells. Int J Cancer. 99:2002;171-178.
51. Lotan R., Xu X.C., Lippman S.M., Ro J.Y., Lee J.S., Lee J.J., Hong W.K. Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin. N Engl J Med. 332:1995;1405-1410.